Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2025-12-24 @ 3:31 PM
NCT ID:
NCT04157192
Eligibility Criteria:
Inclusion Criteria:
* All patients with two to eight bouts of migraine without an aura per month
* All patient aged (≥) 18 to (≤) 60 years old
* All patients who have not had a bout of migraine in the last 24 hours
* All patients who have given free informed consent and have signed the consent form.
* All patients who are affiliated to or beneficiaries of a health insurance scheme
* All patients available for a two-month follow-up
Exclusion Criteria:
* All patients with migraine which is secondary to a neurological, neuropsychiatric, or vascular disorder
* All patients suffering from diabetes
* All patients with a past history of alcohol or drug abuse
* All patients with contraindications for an MRI scan
* All patients on antidepressants or Botox.
* All patients already taking part in Category 1 research involving the human person
* All patients on an exclusion period determined by another study
* All patients placed under judicial protection, guardianship, or supervision
* All patients for whom it is impossible to give the subject clear information
* All patients who are pregnant, about to give birth or breastfeeding
* All patient who have received botulinum toxin in the past year
* All patient who have undergone antidepressant treatment in the last 2 months
* All patient who have started a background migraine treatment for less than 3 months
* All patient who have more than 14 migraine days per month
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT04157192
Study Brief:
Protocol Section:
NCT04157192